Yohei Koizumi
Overview
Explore the profile of Yohei Koizumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
1623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, et al.
J Gastroenterol Hepatol
. 2025 Jan;
PMID: 39762722
Aim: This study aimed to compare the prognostic performance of the risk models for patients with hepatocellular carcinoma (HCC) receiving atezolizumab and bevacizumab (Atez/Bev) as first-line treatment. Methods: Among 449...
2.
Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, et al.
Sci Rep
. 2025 Jan;
15(1):72.
PMID: 39747852
In the current era of immune therapy, lenvatinib (LEN) continues to be vital for treating unresectable hepatocellular carcinoma (uHCC) patients. This study investigates the importance of nutritional status in the...
3.
Gotoh T, Kumada T, Ogawa S, Niwa F, Toyoda H, Hirooka M, et al.
Liver Int
. 2024 Dec;
45(1):e16210.
PMID: 39673700
Background And Aims: This study prospectively compared the diagnostic accuracies of the improved Attenuation Measurement (iATT) algorithm and the Controlled Attenuation Parameter (CAP) and assessed the interchangeability of iATT with...
4.
Imai Y, Koizumi Y, Hiasa Y, Hirooka M, Tokumoto Y, Yoshida O, et al.
J Gastroenterol
. 2024 Dec;
60(1):24-31.
PMID: 39652102
Background: Direct measurement of portal venous pressure (PVP) is invasive, so the hepatic venous pressure gradient (HVPG) is commonly measured to evaluate portal hypertension (PH). HVPG is the gold standard...
5.
Liu S, Li J, Wong Y, Yim H, Hirooka M, Enomoto H, et al.
MedComm (2020)
. 2024 Nov;
5(11):e781.
PMID: 39492833
Baveno VII criteria (B7C) and Baveno VI criteria (B6C) have been widely used to estimate the risk of hepatic decompensation. However, the impact of age on these criteria warrants further...
6.
Persano M, Casadei-Gardini A, Tada T, Suda G, Shimose S, Kudo M, et al.
Oncology
. 2024 Oct;
:1-13.
PMID: 39396495
Introduction: The most frequently used first-line treatment in patients with advanced hepatocellular carcinoma (HCC) is atezolizumab plus bevacizumab. Upon progression after this treatment, the standard of care in many countries...
7.
Rossari F, Tada T, Suda G, Shimose S, Kudo M, Yoo C, et al.
Liver Cancer
. 2024 Sep;
13(5):522-536.
PMID: 39296620
Introduction: The impact of etiology on response to immunotherapy in advanced hepatocellular carcinoma (HCC) is being debated, with contrasting findings between early and recent post hoc analyses of IMbrave-150 and...
8.
Miyake T, Furukawa S, Matsuura B, Yoshida O, Kanamoto A, Miyazaki M, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39193707
Context: Estimated remnant cholesterol (Rem-C) level, a risk factor for cardiovascular disease (CVD), is associated with metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosed via ultrasonography. However, the relationship between accurate...
9.
Liu C, You H, Zeng Q, Wong Y, Wang B, Grgurevic I, et al.
Clin Mol Hepatol
. 2024 Jul;
31(1):105-118.
PMID: 38988296
Backgrounds/aims: Non-invasive models stratifying clinically significant portal hypertension (CSPH) are limited. Herein, we developed a new non-invasive model for predicting CSPH in patients with compensated cirrhosis and investigated whether carvedilol...
10.
Nakamura Y, Hirooka M, Koizumi Y, Yano R, Imai Y, Watanabe T, et al.
J Med Ultrason (2001)
. 2024 Jun;
52(1):85-94.
PMID: 38918301
Purpose: This retrospective study was conducted to investigate the diagnostic accuracy of ultrasound-derived fat fraction (UDFF) for grading hepatic steatosis using liver histology as the reference standard. Methods: Seventy-three patients...